ORBIMED ADVISORS LLC Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for February 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2021 | DBTX | Decibel Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,158,412 | 0 | 0 | |
Feb 19 2021 | DBTX | Decibel Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,737,619 | 0 | 0 | |
Feb 19 2021 | DBTX | Decibel Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 14,480,162 | 0 | 0 | |
Feb 19 2021 | DBTX | Decibel Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 555,566 | 10,000,188 | 883,418 | 327.9 K to 883.4 K (+169.46 %) |
Feb 19 2021 | DBTX | Decibel Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 1,111,100 | 19,999,800 | 3,843,206 | 2.7 M to 3.8 M (+40.67 %) |
Feb 19 2021 | DBTX | Decibel Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 218,568 | 0 | 218,568 | 0 to 218.6 K |
Feb 19 2021 | DBTX | Decibel Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 327,852 | 0 | 327,852 | 0 to 327.9 K |
Feb 19 2021 | DBTX | Decibel Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,732,106 | 0 | 2,732,106 | 0 to 2.7 M |
Feb 19 2021 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.50 | 1,285,714 | 4,499,999 | 8,053,298 | 6.8 M to 8.1 M (+19.00 %) |
Feb 18 2021 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 13.00 | 104,050 | 1,352,650 | 396,657 | 292.6 K to 396.7 K (+35.56 %) |
Feb 18 2021 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 13.00 | 420,299 | 5,463,887 | 5,243,259 | 4.8 M to 5.2 M (+8.71 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 918,295 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 612,196 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,071,428 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 714,285 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 285,000 | 4,845,000 | 2,274,723 | 2 M to 2.3 M (+14.32 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 190,000 | 3,230,000 | 1,516,481 | 1.3 M to 1.5 M (+14.32 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,989,723 | 0 | 1,989,723 | 0 to 2 M |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,326,481 | 0 | 1,326,481 | 0 to 1.3 M |